Genomics of pancreatic ductal adenocarcinoma.

[1]  F. Chibon,et al.  Remarkable Response to Crizotinib in Woman With Anaplastic Lymphoma Kinase-Rearranged Anaplastic Thyroid Carcinoma. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  C. Plass,et al.  Early epigenetic downregulation of WNK2 kinase during pancreatic ductal adenocarcinoma development , 2014, Oncogene.

[3]  N. Adsay,et al.  Molecular genetics of pancreatic neoplasms and their morphologic correlates: an update on recent advances and potential diagnostic applications. , 2014, American journal of clinical pathology.

[4]  S. Clark,et al.  Mining cancer methylomes: prospects and challenges. , 2014, Trends in genetics : TIG.

[5]  Andrew E. Teschendorff,et al.  ChAMP: 450k Chip Analysis Methylation Pipeline , 2014, Bioinform..

[6]  Kun Wang,et al.  Methylation-mediated silencing of the miR-124 genes facilitates pancreatic cancer progression and metastasis by targeting Rac1 , 2014, Oncogene.

[7]  W. Lam,et al.  SOX15 is a candidate tumor suppressor in pancreatic cancer with a potential role in Wnt/β-catenin signaling , 2014, Oncogene.

[8]  Chun-you Wang,et al.  Hypermethylation of HIC1 Promoter and Aberrant Expression of HIC1/SIRT1 Might Contribute to the Carcinogenesis of Pancreatic Cancer , 2013, Annals of Surgical Oncology.

[9]  F. Motoi,et al.  Suppressed expression of NDRG2 correlates with poor prognosis in pancreatic cancer. , 2013, Biochemical and biophysical research communications.

[10]  A. R. Brannon,et al.  "N of 1" case reports in the era of whole-genome sequencing. , 2013, The Journal of clinical investigation.

[11]  L. Elnitski,et al.  Recurrent patterns of DNA methylation in the ZNF154, CASP8, and VHL promoters across a wide spectrum of human solid epithelial tumors and cancer cell lines , 2013, Epigenetics.

[12]  Joshua M. Stuart,et al.  The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.

[13]  M. Dong,et al.  NPTX2 Hypermethylation in Pure Pancreatic Juice Predicts Pancreatic Neoplasms , 2013, The American journal of the medical sciences.

[14]  M. Vandewoestyne,et al.  Laser capture microdissection: should an ultraviolet or infrared laser be used? , 2013, Analytical biochemistry.

[15]  Eric-Wubbo Lameijer,et al.  Identification and systematic annotation of tissue-specific differentially methylated regions using the Illumina 450k array , 2013, Epigenetics & Chromatin.

[16]  Z. Szallasi,et al.  Parallel evolution of tumour subclones mimics diversity between tumours , 2013, The Journal of pathology.

[17]  D. Aust,et al.  Pathohistological Subtype Predicts Survival in Patients With Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas , 2013, Annals of surgery.

[18]  Jingnan Li,et al.  ppENK Gene Methylation Status in the Development of Pancreatic Carcinoma , 2013, Gastroenterology research and practice.

[19]  J. Mendelsohn.  Personalizing oncology: perspectives and prospects. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  H. Craighead,et al.  Single-molecule analysis of combinatorial epigenomic states in normal and tumor cells , 2013, Proceedings of the National Academy of Sciences.

[21]  Winnie S. Liang,et al.  Comparative RNA-Seq and Microarray Analysis of Gene Expression Changes in B-Cell Lymphomas of Canis familiaris , 2013, PloS one.

[22]  Jae Keun Kim,et al.  P16 Hypermethylation Predicts Surgical Outcome Following Curative Resection of Mid/Distal Bile Duct Cancer , 2013, Annals of Surgical Oncology.

[23]  S. Ogawa,et al.  Deep sequencing in cancer research. , 2013, Japanese journal of clinical oncology.

[24]  A. Jemal,et al.  Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.

[25]  Lincoln D. Stein,et al.  Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes , 2012, Nature.

[26]  K. Heichman,et al.  DNA methylation biomarkers and their utility for solid cancer diagnostics , 2012, Clinical chemistry and laboratory medicine.

[27]  Y. Gong,et al.  Neuronal pentraxin II (NPTX2) Is Frequently Down-Regulated by Promoter Hypermethylation in Pancreatic Cancers , 2012, Digestive Diseases and Sciences.

[28]  M. Li,et al.  Clinical implications of mismatched repair gene promoter methylation in pancreatic cancer , 2012, Medical Oncology.

[29]  P. A. Futreal,et al.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.

[30]  Zhaohui Lu,et al.  Aberrant Methylation of RASSF2A in Human Pancreatic Ductal Adenocarcinoma and Its Relation to Clinicopathologic Features , 2012, Pancreas.

[31]  E. Giovannetti,et al.  Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice. , 2012, Critical reviews in oncology/hematology.

[32]  Johan T den Dunnen,et al.  Increased sensitivity of next generation sequencing-based expression profiling after globin reduction in human blood RNA , 2012, BMC Genomics.

[33]  J. Ryu,et al.  The Role of Quantitative NPTX2 Hypermethylation as a Novel Serum Diagnostic Marker in Pancreatic Cancer , 2012, Pancreas.

[34]  Noriyuki Omura,et al.  Genome-Wide CpG Island Profiling of Intraductal Papillary Mucinous Neoplasms of the Pancreas , 2011, Clinical Cancer Research.

[35]  D. Aust,et al.  Hepatocyte Nuclear Factor (HNF) 4&agr; Expression Distinguishes Ampullary Cancer Subtypes and Prognosis After Resection , 2011, Annals of surgery.

[36]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[37]  A. Børresen-Dale,et al.  Identification of fusion genes in breast cancer by paired-end RNA-sequencing , 2011, Genome Biology.

[38]  Jeffrey W. Clark,et al.  Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. , 2010, The New England journal of medicine.

[39]  Ryan D. Morin,et al.  Mutation of FOXL2 in granulosa-cell tumors of the ovary. , 2009, The New England journal of medicine.

[40]  Lee E. Edsall,et al.  Human DNA methylomes at base resolution show widespread epigenomic differences , 2009, Nature.

[41]  A. Jimeno,et al.  Characterizing DNA methylation patterns in pancreatic cancer genome , 2009, Molecular oncology.

[42]  A. Jemal,et al.  An overview of the cancer burden for primary care physicians. , 2009, Primary care.

[43]  Robert Grützmann,et al.  Neuroendocrine tumors of the pancreas. , 2009, The oncologist.

[44]  R. Durbin,et al.  Mapping Quality Scores Mapping Short Dna Sequencing Reads and Calling Variants Using P

, 2022 .

[45]  G. Parmigiani,et al.  Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.

[46]  C. Pilarsky,et al.  Recent patents concerning diagnostic and therapeutic applications of aberrantly methylated sequences in pancreatic cancer. , 2008, Recent patents on DNA & gene sequences.

[47]  R. Hruban,et al.  CpG island methylation profile of pancreatic intraepithelial neoplasia , 2008, Modern Pathology.

[48]  H. Friess,et al.  Activation of Wnt signalling in stroma from pancreatic cancer identified by gene expression profiling , 2008, Journal of cellular and molecular medicine.

[49]  Bela Molnar,et al.  DNA methylation biomarkers for blood-based colorectal cancer screening. , 2008, Clinical chemistry.

[50]  C. Croce,et al.  A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[51]  Christian Pilarsky,et al.  Meta-analysis of microarray data on pancreatic cancer defines a set of commonly dysregulated genes , 2005, Oncogene.

[52]  C. Pilarsky,et al.  Gene Expression Analysis of Pancreatic Cell Lines Reveals Genes Overexpressed in Pancreatic Cancer , 2005, Pancreatology.

[53]  R. Schmid,et al.  Pancreatic cancer: basic and clinical aspects. , 2005, Gastroenterology.

[54]  C. Pilarsky,et al.  Gene expression profiling of microdissected pancreatic ductal carcinomas using high-density DNA microarrays. , 2004, Neoplasia.

[55]  C. Croce,et al.  The Tumor Suppressor Gene WWOX at FRA16D Is Involved in Pancreatic Carcinogenesis , 2004, Clinical Cancer Research.

[56]  Christian Pilarsky,et al.  WIF1, a component of the Wnt pathway, is down‐regulated in prostate, breast, lung, and bladder cancer , 2003, The Journal of pathology.

[57]  C. Pilarsky,et al.  Systematic Isolation of Genes Differentially Expressed in Normal and Cancerous Tissue of the Pancreas , 2003, Pancreatology.

[58]  M. Adams,et al.  Shotgun Sequencing of the Human Genome , 1998, Science.

[59]  J. Craig Venter,et al.  Sequence identification of 2,375 human brain genes , 1992, Nature.

[60]  H. Nakhasi,et al.  Covalent modification and repressed transcription of a gene in hepatoma cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[61]  J. Li,et al.  Epigenetic inactivation of the canonical Wnt antagonist secreted frizzled-related protein 1 in hepatocellular carcinoma cells. , 2012, Neoplasma.

[62]  M. Esteller,et al.  DNA methylation and cancer. , 2010, Advances in genetics.